TerminatedNot Applicable

Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction

Stopped: Difficulty in recruiting patients

France27 participantsStarted 2016-06-13

Plain-language summary

The aim of the study is to estimate the contribution of abdominal imaging by magnetic resonance Imaging (MRI) and abdominal scanner in the detection of subdiaphragmatic infarction associated to the atrial fibrillation in the cerebral infarction.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient over 18 * Patient having a CHADS-VAsc Score ≥ 2; * Patient hospitalized for a secondary established ischemic accident in an atrial fibrillation not anticoagulated (INR\<2 and/or receiving antiplatelet (aspirin, clopidogrel)) for less than 14 days; * Patient affiliated to a national insurance scheme or beneficiary * Patient having given a written consent Exclusion Criteria: * Patient presenting cognitive disorders incompatible with the planned examinations (MRI / SCANNER). * Pacemaker or implantable defibrillator, or other contraindication in the MRI (metallic eye brightness, intra cerebral clip). * Contraindication in injected scanner. * Current pregnancy

What they're measuring

Number of patients with subdiaphragmatic infarctions detected by abdominal MRI

Timeframe: 14 days

Trial details

NCT IDNCT02948140

SponsorHopital Foch

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12

View on ClinicalTrials.gov More Stroke trials